TY  - GEN
AU  - Monk,Bradley J
TI  - Optimal treatment for platinum-sensitive recurrent ovarian cancer
SN  - 1543-0790
PY  - 2018///0815
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Clinical Decision-Making
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Molecular Targeted Therapy
KW  - Ovarian Neoplasms
KW  - drug therapy
KW  - Platinum
KW  - administration & dosage
KW  - Recurrence
KW  - Retreatment
KW  - Treatment Outcome
N1  - Publication Type: Interview
ER  -